Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.
Launay O, Roudière L, Boukli N, Dupont B, Prévoteau du Clary F, Patey O, David F, Lortholary O, Devidas A, Piketty C, Rey E, Urbinelli R, Allaert FA, Tréluyer JM, Caumes E; Viramune-Zyrtec Study Group.
Launay O, et al. Among authors: treluyer jm.
Clin Infect Dis. 2004 Apr 15;38(8):e66-72. doi: 10.1086/382677. Epub 2004 Mar 29.
Clin Infect Dis. 2004.
PMID: 15095233
Clinical Trial.